Successful Establishment of an Orthotopic Hepatoblastoma In Vivo Model in NOD/LtSz-scid IL2Rγnull Mice
2011

Establishing a Model for Hepatoblastoma in Mice

Sample size: 22 publication Evidence: moderate

Author Information

Author(s): Verena Ellerkamp, Sorin Armeanu-Ebinger, Julia Wenz, Steven W. Warmann, Juergen Schäfer, Peter Ruck, Joerg Fuchs

Primary Institution: Children's University Hospital Tuebingen, Germany

Hypothesis

Can an orthotopic model for hepatoblastoma be established in mice to better reflect tumor behavior?

Conclusion

The study successfully established a reproducible intrahepatic model for hepatoblastoma in mice, showing high tumor incidence and enabling better monitoring of tumor growth.

Supporting Evidence

  • 85% of mice injected with HuH6 cells developed intrahepatic tumors after splenectomy.
  • The model allows for non-invasive monitoring of tumor growth using MRI.
  • Increased levels of serum Alpha-fetoprotein and Gaussia luciferase were observed after tumor-cell inoculation.

Takeaway

Researchers created a new way to study liver tumors in mice that helps them understand how these tumors grow and respond to treatments better.

Methodology

The study involved injecting hepatoblastoma cell lines into the spleens of mice, followed by splenectomy to promote intrahepatic tumor growth.

Potential Biases

Potential bias due to the use of a specific mouse strain that may not fully represent human tumor biology.

Limitations

The model's reliance on splenectomy may limit its applicability in studies involving hematopoietic stem cell engraftment.

Participant Demographics

NOD/LtSz-scid IL2Rγnull mice, 4- to 6-week-old, both male and female.

Statistical Information

Statistical Significance

p>0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0023419

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication